Adverse Drug Reaction Reporting Program of the Ontario Medical Association: the first 3 years

Area of Science:

• Pharmacovigilance
• Drug Safety Monitoring

Background:

• Adverse drug reactions pose a significant public health risk.
• Effective reporting systems are crucial for monitoring drug safety.
• The Ontario Medical Association's Committee on Drugs and Pharmaco-therapy established a reporting program.

Purpose of the Study:

• To describe the Adverse Drug Reaction Reporting Program.
• To analyze trends identified from reported adverse drug events.
• To review clinical observations derived from the program's data.

Main Methods:

• Development and operation of a pharmacovigilance program.
• Analysis of submitted adverse drug reaction reports.
• Review of clinical observations based on aggregated data.

Main Results:

• The program facilitates the collection of adverse drug reaction data.
• Analysis reveals trends in drug safety.
• Quarterly circulation of reports informs healthcare professionals.

Conclusions:

• The Adverse Drug Reaction Reporting Program is a valuable tool for pharmacovigilance.
• Data analysis provides insights into drug safety trends.
• Dissemination of findings supports evidence-based clinical practice.